CVR: 43575627
DKK -12,630
Gross profit
Net result: DKK -11,150
Ebumab Holding ApS
CVR · view ownership and management
Director registered: Hans Heugh Wandall
CVR · 12/10/2022
View the full event history
Ebumab Sandbox ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The company is owned by Ebumab Holding ApS. In 2025, the company reported a gross profit of DKK -12,630 and a net result of DKK -11,150 compared with DKK -7,800 the year before. Equity in the 2025 report amounted to DKK 15,192.
Selskabets formål er drive virksomhed indenfor forskning, udvikling og markedsføring af farmaceutiske og medicinske præparater samt anden efter bestyrelsens skøn beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEbumab Sandbox ApS was founded on 12 October 2022.
Ebumab Sandbox ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Ebumab Sandbox ApS is owned by Ebumab Holding ApS.
In 2025, Ebumab Sandbox ApS reported a gross profit of DKK -12,630.
The management of Ebumab Sandbox ApS consists of Hans Heugh Wandall and Johan Henrik Faber.
Ebumab Sandbox ApS is located at Ole Maaløes Vej 3, 2200 København N.
Claim this page to add your logo and social links. Free to get started.
Ebumab Sandbox ApS has published its annual report for 2025. Gross profit came to DKK -12,630, and the net result was DKK -11,150.
Ebumab Sandbox ApS has published its annual report for 2024. Gross profit came to DKK -10,000, and the net result was DKK -7,800.
As of February 25, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Ebumab Sandbox ApS.
As of February 25, 2025, Slotsgade Revision ApS has stepped down as auditor of Ebumab Sandbox ApS.
Ebumab Sandbox ApS has published its interim report for the period October 12, 2022 – December 31, 2023.
As of October 12, 2022, Slotsgade Revision ApS has been appointed auditor of Ebumab Sandbox ApS.
As of October 12, 2022, Hans Heugh Wandall has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Johan Henrik Faber has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Søren Erik Bjørn has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Ebumab Sandbox ApS.
As of October 12, 2022, Hans Heugh Wandall is registered as adm. dir. of Ebumab Sandbox ApS.
As of October 12, 2022, Johan Henrik Faber is registered as director of Ebumab Sandbox ApS.
As of October 12, 2022, Ebumab Holding ApS is registered as an owner of Ebumab Sandbox ApS with an ownership share of 100%.
Ebumab Sandbox ApS was founded on October 12, 2022.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
